Literature DB >> 17502238

The future of HIV prevention: control of sexually transmitted infections and circumcision interventions.

Vikrant V Sahasrabuddhe1, Sten H Vermund.   

Abstract

Prevention and control of sexually transmitted infections (STIs) has proven effective in reducing HIV infection when treatment is available promptly for symptomatic persons in conditions of an emerging epidemic. Biologically, it is assumed that reduced genital tract inflammation reduces infectiousness for HIV as well as reducing susceptibility in HIV-uninfected persons. Male circumcision has been demonstrated effective in reducing risk for HIV infection in three separate trials from South Africa, Kenya, and Uganda. Global expansion of STI treatment and male circumcision programs are vital tools for control of HIV infection; current evidence is reviewed and research priorities are presented.

Entities:  

Mesh：

Year:  2007        PMID： 17502238      PMCID： PMC2700301          DOI： 10.1016/j.idc.2007.03.005

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  97 in total

Review 1.  Back to basics in HIV prevention: focus on exposure.

Authors:  Elizabeth Pisani; Geoff P Garnett; Nicholas C Grassly; Tim Brown; John Stover; Catherine Hankins; Neff Walker; Peter D Ghys
Journal:  BMJ       Date:  2003-06-21

2.  Asia--the next frontier for HIV/AIDS. Two hard-hit countries offer rare success stories: Thailand and Cambodia.

Authors:  Jon Cohen
Journal:  Science       Date:  2003-09-19       Impact factor: 47.728

Review 3.  The role of sexually transmitted diseases in HIV transmission.

Authors:  Shannon R Galvin; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

Review 4.  Population-based interventions for reducing sexually transmitted infections, including HIV infection.

Authors:  P Sangani; G Rutherford; D Wilkinson
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 5.  Partner reduction is crucial for balanced "ABC" approach to HIV prevention.

Authors:  James D Shelton; Daniel T Halperin; Vinand Nantulya; Malcolm Potts; Helene D Gayle; King K Holmes
Journal:  BMJ       Date:  2004-04-10

6.  Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings.

Authors:  Jeffrey S A Stringer; Moses Sinkala; Julia P Stout; Robert L Goldenberg; Edward P Acosta; Victoria Chapman; Rosemary Kumwenda-Phiri; Sten H Vermund
Journal:  J Acquir Immune Defic Syndr       Date:  2003-04-15       Impact factor: 3.731

7.  The impact of syndromic treatment of sexually transmitted diseases on genital shedding of HIV-1.

Authors:  Dawit Wolday; Zeru Gebremariam; Zemzem Mohammed; Wendelien Dorigo-Zetsma; Hailu Meles; Tsehaynesh Messele; Aberra Geyid; Eduard Sanders; Shlomo Maayan
Journal:  AIDS       Date:  2004-03-26       Impact factor: 4.177

Review 8.  Male circumcision for prevention of heterosexual acquisition of HIV in men.

Authors:  N Siegfried; M Muller; J Volmink; J Deeks; M Egger; N Low; H Weiss; S Walker; P Williamson
Journal:  Cochrane Database Syst Rev       Date:  2003

9.  A comparison of cost-effectiveness of three protocols for diagnosis and treatment of gonococcal and chlamydial infections in women in Africa.

Authors:  Nuriye Nalan Sahin-Hodoglugil; Rebecca Woods; Audrey Pettifor; Julia Walsh
Journal:  Sex Transm Dis       Date:  2003-05       Impact factor: 2.830

10.  The cost-effectiveness of syndromic management in pharmacies in Lima, Peru.

Authors:  Elisabeth J Adams; Patricia J Garcia; Geoffrey P Garnett; W John Edmunds; King K Holmes
Journal:  Sex Transm Dis       Date:  2003-05       Impact factor: 2.830
View more
  6 in total

1.  Correlates of HIV infection among patients with mental illness in Brazil.

Authors:  Mark D C Guimarães; Karen McKinnon; Francine Cournos; Carla J Machado; Ana Paula S Melo; Lorenza N Campos; Milton L Wainberg
Journal:  AIDS Care       Date:  2013-09-02

2.  Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version).

Authors:  Sumit Dave; Kourosh Afshar; Luis H Braga; Peter Anderson
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

Review 3.  The HIV Epidemic: High-Income Countries.

Authors:  Sten H Vermund; Andrew J Leigh-Brown
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

4.  Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.

Authors:  Ouzama Nicholson; Fay DiCandilo; James Kublin; Xiao Sun; Erin Quirk; Michelle Miller; Glenda Gray; Jean Pape; Michael N Robertson; Devan V Mehrotra; Steven Self; Katherine Turner; Jorge Sanchez; Punnee Pitisuttithum; Ann Duerr; Sheri Dubey; Lisa Kierstead; Danilo Casimiro; Scott M Hammer For The Merck V/Hiv Vaccine Trials Network Study Team
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-23       Impact factor: 2.205

Review 5.  Male circumcision and HIV infection risk.

Authors:  John N Krieger
Journal:  World J Urol       Date:  2011-05-18       Impact factor: 4.226

6.  Key Determinants of Human α-Defensin 5 and 6 for Enhancement of HIV Infectivity.

Authors:  Kimyata Valere; Wuyuan Lu; Theresa L Chang
Journal:  Viruses       Date:  2017-08-29       Impact factor: 5.048
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.